TOP STORIES

• REGULATORY Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
  February 27, 2020

• BUSINESS Fujifilm Receives Avigan Supply Requests from Overseas amid Coronavirus Outbreak
  February 27, 2020

• BUSINESS Drug Makers in Japan Upping Coronavirus Measures; Takeda Switches to Online Interviews for New R&D Hires
  February 26, 2020

• REGULATORY Japan Approves Label Expansions for Rozlytrek, Alecensa and More
  February 25, 2020

• BUSINESS “Tender Process Needs to Be Improved” in Response to Bid-Rigging Scandal by Top 4 Wholesalers: Hospital Management Advisor
  February 25, 2020

• ORGANIZATION Japan Pharma Lobbies Likely to Retain Chiefs as Off-Year Re-Pricing Debate Looms
  February 21, 2020

• BUSINESS Takeda Vaults to 9th in Global Pharma Ranking after Shire Buy, Roche Tops List: Jiho Tally
  February 21, 2020

• BUSINESS GSK Japan Resurrects “Sales” for Rep Performance Review, Doctor Payments; Critics Say It’s a Rollback
  February 20, 2020

• BUSINESS Japan Pharma Market Logs 1st Growth in 3 Years in 2019, Keytruda Is the Best-Seller: IQVIA
  February 19, 2020

• REGULATORY Authorized Generics for Memary, Celecox among Approval List towards June Listing
  February 18, 2020

• REGULATORY MHLW Panel to Review Nippon Shinyaku’s Oligonucleotide DMD Drug, Latuda and More on Feb. 28
  February 18, 2020

• REGULATORY Zolgensma Up for Japan Advisory Panel Meeting on Feb. 26, Listing Expected as Early as May
  February 17, 2020

• BUSINESS Eisai Pulls Belviq from US Market after FDA Flags Cancer Risks
  February 17, 2020

• REGULATORY MHLW to Weigh All-Year Invitation for Sakigake Requests: Top Pharmacy Officer
  February 14, 2020

• BUSINESS Ono Revamps Japan Sales Structure to Gear Up for New Launches
  February 13, 2020

• REGULATORY MHLW Calls for Stable Supplies of HIV Drugs amid Coronavirus Outbreak
  February 13, 2020

• BUSINESS With 2 New Deals Inked, Meiji Hunkering Down for Full-Scale Entry into Hematology Market
  February 12, 2020

• ORGANIZATION FPMAJ Creates Scheme to Deal with Drug Supply Disruptions; Companies to Set Up “Supply Adjustment Teams”
  February 12, 2020

• INTERVIEW Improper Materials Apparently Decreased after Promotion Guidelines Introduced: Pharmacist
  February 10, 2020

• BUSINESS With Orix Deal, Reborn Kobayashi Kako Aims to Become Follow-Up to Big 3 Generic Players
  February 7, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 124
• 125
• 126
• 127
• 128
• 129
• 130
• 131
• 132
• …
• Next ›
• 最終 »